36 results on '"Talayero, Paloma"'
Search Results
2. 407.1: Experimental Assay of Intestinal Graft Viability and Function After Regional Abdominal Normothermic Perfusion
3. 317.8: Antibody-Removal Therapies in Pediatric Intestinal and Multivisceral Recipients: Why, When and How? A Single-Center Experience
4. 317.7: qPCR Based Immunotherapy in Intestinal Transplant Recipients and Candidates
5. IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
6. Preclinical Study of DCD and Normothermic Perfusion for Visceral Transplantation
7. 46: The fall of a myth: the first three cases of DCD in intestinal transplantation
8. 63: DCD in intestinal transplantation: the path to prove its validity in both experimental and clinical models
9. 5-gene differential expression predicts stability of human intestinal allografts
10. CLINICAL-EXPERIMENTAL EXPERIENCE WITH RAPAMYCIN IN VISCERAL TRANSPLANTATION
11. Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
12. PEDIATRIC INTESTINAL RETRANSPLANTATION: OUTCOMES IN A REFERAL CENTER
13. Immune response in an experimental model of pig to rabbit abdominal fascia transplantation.
14. Experimental Assessment of Intestinal Damage in Controlled Donation After Circulatory Death for Visceral Transplantation
15. First case report of multivisceral transplant from a deceased cardiac death donor
16. Helper Innate Lymphoid Cells (hILC) resist Immunosuppressive Therapy: an Observation from Kidney and Liver Transplantation
17. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity
18. Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits
19. Toward Sézary Syndrome immunotherapy
20. Graft infusion of adipose‐derived mesenchymal stromal cells to prevent rejection in experimental intestinal transplantation: A feasibility study
21. IL-6–based mortality risk model for hospitalized patients with COVID-19
22. Novel coronavirus (SARS‐CoV‐2) infection in a patient with multivisceral transplant
23. Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long‐term in human intestinal grafts – a descriptive study
24. Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients – a single centre cohort study
25. P4.46: PEDIATRIC INTESTINAL RETRANSPLANTATION: OUTCOMES IN A REFERAL CENTER
26. P4.12: Immune response in an experimental model of pig to rabbit abdominal fascia transplantation.
27. Donor‐Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching
28. Novel coronavirus (SARS‐CoV‐2) infection in a patient with multivisceral transplant.
29. 5-gene differential expression predicts stability of human intestinal allografts
30. High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients
31. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity
32. High Proportion of Pretransplantation Activated Regulatory T cells (CD4+CD25highCD62L+CD45RO+) Predicts Acute Rejection in Kidney Transplantation
33. Harmful Effect of Preformed Anti-MICA Antibodies on Renal Allograft Evolution in Early Posttransplantation Period
34. High Proportion of Pretransplantation Activated Regulatory T cells (CD4+CD25highCD62L+CD45RO+) Predicts Acute Rejection in Kidney Transplantation.
35. Perforin gene variant A91V in young patients with severe COVID-19.
36. Phenotypic and functional evaluation of CD3+CD4-CD8- T cells in human CD8 immunodeficiency.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.